{
  "id": "dic_recognition_cues_selectAll_v1",
  "type": "selectAll",
  "stem": "The nurse is caring for a client with septic shock. Which findings indicate the development of Disseminated Intravascular Coagulation (DIC)?",
  "options": [
    {
      "id": "e",
      "text": "Prolonged Prothrombin Time (PT) and Partial Thromboplastin Time (PTT)."
    },
    {
      "id": "b",
      "text": "Petechiae and purpura on the chest and extremities."
    },
    {
      "id": "c",
      "text": "Increased FDP (Fibrin Degradation Products) and D-dimer levels."
    },
    {
      "id": "a",
      "text": "Bleeding or oozing from intravenous (IV) insertion sites."
    },
    {
      "id": "f",
      "text": "Decreased fibrinogen levels."
    },
    {
      "id": "d",
      "text": "Platelet count has increased from 150,000 to 450,000/mm³."
    }
  ],
  "correctOptionIds": [
    "a",
    "b",
    "c",
    "e",
    "f"
  ],
  "pedagogy": {
    "bloomLevel": "analyze",
    "cjmmStep": "recognizeCues",
    "nclexCategory": "Physiological Adaptation",
    "difficulty": 4,
    "topicTags": [
      "Hematology",
      "Sepsis",
      "Critical Care",
      "Coagulation Disorders"
    ],
    "questionTrap": "The primary trap is the paradoxical nature of DIC, which involves simultaneous widespread clotting (thrombosis) and severe bleeding (hemorrhage). Test-takers may incorrectly focus on only one aspect. The key is recognizing that the systemic bleeding is a direct result of the massive consumption of platelets and clotting factors during the initial, widespread thrombotic phase.",
    "mnemonics": "To remember the lab profile for DIC, think: 'DIC' = D-dimer HIGH, Increased PT/PTT, Consumed platelets & fibrinogen (LOW). Common triggers can be recalled with 'Stop Making New Thrombi': Sepsis, Trauma, Obstetric complications, Pancreatitis, Malignancy, Nephrotic syndrome, Transfusion.",
    "clinicalPearls": "Early recognition of DIC is crucial. Monitor patients at risk (e.g., sepsis, trauma, obstetric complications) for signs of bleeding, thrombosis, and changes in lab values. Prompt intervention with supportive care and treatment of the underlying cause can improve outcomes. Consider the SBAR communication tool for effective reporting.",
    "sbarExample": {
      "situation": "Client with septic shock exhibiting new onset petechiae and oozing from IV site.",
      "background": "Client admitted 0800 for pneumonia, developed septic shock. Current vitals: BP 90/60, HR 120, RR 28, SpO2 92% on 2L NC. Labs pending.",
      "assessment": "Suspect Disseminated Intravascular Coagulation (DIC) based on clinical presentation. Noted petechiae on chest and extremities, oozing from IV site.",
      "recommendation": "Recommend STAT coagulation studies (PT, PTT, fibrinogen, D-dimer, platelet count). Consider administering platelets and/or cryoprecipitate per protocol. Monitor closely for further bleeding or thrombosis. Consult hematology."
    }
  },
  "answerBreakdown": [
    {
      "optionId": "e",
      "isCorrect": true,
      "content": "**Rationale:** This finding reflects the depletion of circulating clotting factors. Prothrombin Time (PT) measures the extrinsic pathway, and Partial Thromboplastin Time (PTT) measures the intrinsic pathway. In DIC, factors from both pathways (e.g., Factor V, VIII, X, prothrombin) are consumed in the widespread clotting process. The resulting deficiency of these factors prolongs the time required for clot formation in laboratory tests. **Pathophysiology:** The uncontrolled activation of the coagulation cascade leads to the formation of microthrombi throughout the vasculature. This process consumes clotting factors faster than the body can replenish them, leading to a deficiency and prolonged PT/PTT.",
      "scoringWeight": 1
    },
    {
      "optionId": "b",
      "isCorrect": true,
      "content": "**Rationale:** These skin manifestations directly result from severe thrombocytopenia and increased capillary fragility. Widespread microvascular thrombosis damages endothelial linings, while the consumption of platelets (often dropping below 50,000/mm³) impairs primary hemostasis. Consequently, spontaneous extravasation of red blood cells from dermal capillaries occurs, presenting as petechiae (pinpoint hemorrhages) and purpura (larger confluent hemorrhages). **Pathophysiology:** The formation of microthrombi damages the endothelial lining of blood vessels, increasing their permeability and fragility. Simultaneously, the consumption of platelets leads to thrombocytopenia, further impairing the body's ability to stop bleeding. This combination results in the characteristic skin manifestations of DIC.",
      "scoringWeight": 1
    },
    {
      "optionId": "c",
      "isCorrect": true,
      "content": "**Rationale:** This is a key diagnostic laboratory finding. The systemic formation of fibrin clots in DIC triggers a secondary, compensatory fibrinolytic response where plasmin actively breaks down these clots. This process generates Fibrin Degradation Products (FDPs). D-dimer, a specific type of FDP from the breakdown of cross-linked fibrin, is a highly specific marker for the active thrombosis and subsequent fibrinolysis that defines the pathophysiology of DIC. **Pathophysiology:** The body attempts to dissolve the widespread microthrombi through fibrinolysis. Plasmin, the enzyme responsible for breaking down fibrin, cleaves the fibrin clots into FDPs, including D-dimer. Elevated levels of D-dimer indicate that both thrombosis and fibrinolysis are occurring simultaneously, a hallmark of DIC.",
      "scoringWeight": 1
    },
    {
      "optionId": "a",
      "isCorrect": true,
      "content": "**Rationale:** This is a hallmark sign of the hemorrhagic phase of DIC. The pathophysiology involves a profound consumption of coagulation factors (e.g., fibrinogen, prothrombin) and platelets during the initial massive microthrombi formation. The resulting severe thrombocytopenia and depletion of clotting factors leave the client unable to form stable clots, even at minor sites of vessel injury like IV insertions or venipuncture sites, leading to persistent oozing. **Pathophysiology:** The consumption of clotting factors and platelets overwhelms the body's ability to maintain hemostasis. Even minor injuries, such as those caused by IV insertion, can lead to uncontrolled bleeding due to the lack of available clotting factors and platelets to form a stable clot.",
      "scoringWeight": 1
    },
    {
      "optionId": "f",
      "isCorrect": true,
      "content": "**Rationale:** Fibrinogen (Factor I) is the soluble precursor to fibrin, the protein that forms the meshwork of a blood clot. During the thrombotic phase of DIC, there is a massive and uncontrolled conversion of fibrinogen to fibrin. This rapid consumption depletes the body's stores of fibrinogen, leading to hypofibrinogenemia. This lack of available fibrinogen critically impairs hemostasis and contributes significantly to the bleeding phase. **Pathophysiology:** The excessive activation of the coagulation cascade leads to the rapid consumption of fibrinogen as it is converted into fibrin to form microthrombi. This depletion of fibrinogen impairs the body's ability to form stable clots, contributing to the bleeding diathesis seen in DIC.",
      "scoringWeight": 1
    },
    {
      "optionId": "d",
      "isCorrect": false,
      "content": "**Rationale:** This finding is the opposite of what occurs in DIC. The defining pathophysiology involves the massive, systemic activation of coagulation, leading to the formation of innumerable microthrombi. Platelets are a primary component of these thrombi and are therefore rapidly consumed. This leads to a precipitous drop in the platelet count, a condition known as consumptive thrombocytopenia. An increase to 450,000/mm³ (thrombocytosis) is inconsistent with the diagnosis. **Pathophysiology:** Platelets are consumed during the formation of microthrombi, leading to a decrease in the circulating platelet count. Thrombocytosis is not a characteristic feature of DIC.",
      "scoringWeight": 0
    }
  ],
  "scoring": {
    "method": "polytomous",
    "maxPoints": 5
  },
  "sentinelStatus": "healed_v2026_v8",
  "rationale": {
    "correct": "Clinical rationale pending deep clinical alignment."
  }
}